AstraZeneca Inks R&D Deal With Ramaswamy's Roivant for Hush-Hush Indication Post author:Sam Post published:October 18, 2017 Post category:BioPharma Vivek Ramaswamy’s parent company, Roivant Sciences, inked a development deal with Astra. Source: BioSpace You Might Also Like Roche Launches The Cobas EGFR Mutation Test V2 For Use With Either Plasma Or Tumor Tissue Samples March 13, 2017 Iconic Sues NantHealth's Over Altor BioScience Stock Fraud October 1, 2017 Backed by Google, Cambridge's Spero Nabs $51.7 Million Series C March 7, 2017
Roche Launches The Cobas EGFR Mutation Test V2 For Use With Either Plasma Or Tumor Tissue Samples March 13, 2017